Your session is about to expire
← Back to Search
Augmented Reality Training + rTMS for Chronic Neck Pain
Study Summary
This trial aims to test if augmented reality sensorimotor training +/or repetitive transcranial magnetic stimulation (rTMS) can reduce chronic neck pain. A feasibility study of 40 patients will be done to test procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have chronic pain that is moderate to severe in parts of my body.You have medical reasons that make transcranial magnetic stimulation not safe for you.I am unable to take part in the study.You have a known mental health condition that affects how well you understand things.I have been diagnosed with chronic neck pain.
- Group 1: Group B (Active)
- Group 2: Group A (Sham)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must an individual meet to join this trial?
"People with chronic neck pain between the ages of 40 and 80 are eligible to take part in this study, which is currently seeking out forty participants."
Are there any vacant spots for participants in this clinical experiment?
"The clinical trial is no longer seeking candidates, as reported on clinicialtrials.gov. Initially posted on July 1st 2023 and last updated May 19th of the same year, this project has been superseded by 81 other trials searching for participants at present."
Does this research endeavor admit participants aged sixty or older?
"To be eligible for this trial, potential participants must have a chronological age between 40 and 80. Additionally, there are two trials available for those under 18 years old as well as 44 options to choose from if you are over 65."
What effects are researchers seeking to achieve with this experiment?
"The primary evaluation of this clinical trial, which will follow the administration of the intervention, is assessing treatment adherence in both groups. Secondary objectives involve measuring pain intensity using a Visual Analog Scale (VAS), Pressure Pain Threshold (PPT) and the Patient Perceived Global Index of Change (PGIC). VAS entails participants indicating their level on a 10 cm line ranging from no pain to worst imaginable; PPT measures deep tissue sensitivity by applying pressure until it turns into an unpleasant sensation; PGIC involves subjects rating their progress as "very much improved,""much improved," etc., according to 1-7 Likert scale."
Share this study with friends
Copy Link
Messenger